| Literature DB >> 26813515 |
F López-Medrano1, J T Silva1, M Fernández-Ruiz1, P L Carver2, C van Delden3, E Merino4, M J Pérez-Saez5, M Montero6, J Coussement7, M de Abreu Mazzolin8, C Cervera9, L Santos10, N Sabé11, A Scemla12, E Cordero13, L Cruzado-Vega14, P L Martín-Moreno15, Ó Len16, E Rudas17, A Ponce de León18, M Arriola19, R Lauzurica20, M David21, C González-Rico22, F Henríquez-Palop23, J Fortún24, M Nucci25, O Manuel26, J R Paño-Pardo27, M Montejo28, P Muñoz29, B Sánchez-Sobrino30, A Mazuecos31, J Pascual5, J P Horcajada6, T Lecompte3, C Lumbreras1, A Moreno9, J Carratalà11, M Blanes32, D Hernández17, E A Hernández-Méndez18, M C Fariñas22, M Perelló-Carrascosa33, J M Morales34, A Andrés34, J M Aguado1.
Abstract
Risk factors for invasive pulmonary aspergillosis (IPA) after kidney transplantation have been poorly explored. We performed a multinational case-control study that included 51 kidney transplant (KT) recipients diagnosed with early (first 180 posttransplant days) IPA at 19 institutions between 2000 and 2013. Control recipients were matched (1:1 ratio) by center and date of transplantation. Overall mortality among cases was 60.8%, and 25.0% of living recipients experienced graft loss. Pretransplant diagnosis of chronic pulmonary obstructive disease (COPD; odds ratio [OR]: 9.96; 95% confidence interval [CI]: 1.09-90.58; p = 0.041) and delayed graft function (OR: 3.40; 95% CI: 1.08-10.73; p = 0.037) were identified as independent risk factors for IPA among those variables already available in the immediate peritransplant period. The development of bloodstream infection (OR: 18.76; 95% CI: 1.04-339.37; p = 0.047) and acute graft rejection (OR: 40.73, 95% CI: 3.63-456.98; p = 0.003) within the 3 mo prior to the diagnosis of IPA acted as risk factors during the subsequent period. In conclusion, pretransplant COPD, impaired graft function and the occurrence of serious posttransplant infections may be useful to identify KT recipients at the highest risk of early IPA. Future studies should explore the potential benefit of antimold prophylaxis in this group. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.Entities:
Keywords: clinical research/practice; epidemiology; fungal; infection and infectious agents; infectious disease; kidney transplantation/nephrology
Mesh:
Year: 2016 PMID: 26813515 DOI: 10.1111/ajt.13735
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086